Pyxis Oncology Inc
(PYXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 2,820 | 0 | 0 | 0 |
| Gross Profit | N/A | 2,820 | N/A | N/A | N/A |
| Operating Expenses | 23,461 | 22,570 | 22,914 | 40,069 | 23,754 |
| Operating Income | -23,461 | -19,750 | -22,914 | -40,069 | -23,754 |
| Other Income | 1,458 | 1,679 | 1,756 | 2,334 | 2,551 |
| Pre-tax Income | -22,003 | -18,071 | -21,158 | -37,735 | -21,203 |
| Income Tax | N/A | 283 | N/A | N/A | N/A |
| Net Income Continuous | -22,003 | -18,354 | -21,158 | -35,571 | -21,203 |
| Net Income | $-22,003 | $-18,354 | $-21,158 | $-35,571 | $-21,203 |
| EPS Basic Total Ops | -0.35 | -0.30 | -0.35 | -0.62 | -0.35 |
| EPS Basic Continuous Ops | -0.35 | -0.30 | -0.35 | -0.62 | -0.35 |
| EPS Diluted Total Ops | -0.35 | -0.30 | -0.35 | -0.62 | -0.35 |
| EPS Diluted Continuous Ops | -0.35 | -0.30 | -0.35 | -0.62 | -0.35 |
| EPS Diluted Before Non-Recurring Items | -0.35 | -0.30 | -0.35 | -0.32 | -0.35 |
| EBITDA(a) | $-23,466 | $-20,111 | $-23,519 | $-41,052 | $-24,675 |